DUTASTERIDE REDUCES PROSTATITIS SYMPTOMS COMPARED TO PLACEBO IN MEN ENROLLED IN THE REDUCE (REDUCTION BY DUTASTERIDE OF PROSTATE CANCER EVENTS) STUDY

被引：1
|
作者：
Nickel, J. Curtis
Tammela, Teuvo L. J.
Teloken, Claudio
Wilson, Timothy H.
Fowler, Ivy L.
Rittmaster, Roger S.
机构：
来源：
JOURNAL OF UROLOGY | 2010年 / 183卷 / 04期
关键词：
D O I：
10.1016/j.juro.2010.02.1473
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
797
引用
收藏
页码：E311 / E312
页数：2
相关论文
共 50 条
  • [21] STATINS SLOW PROSTATE GROWTH: RESULTS FROM THE REDUCTION BY DUTASTERIDE OF CANCER EVENTS (REDUCE) TRIAL
    Muller, Roberto
    Gerber, Leah
    Moreira, Daniel
    Andriole, Gerald
    Parsons, J. Kellogg
    Fleshner, Neil
    Freedland, Stephen
    [J]. JOURNAL OF UROLOGY, 2012, 187 (04): : E505 - E505
  • [22] The predictive value of HGPIN and ASAP for the subsequent diagnosis of prostate cancer in the Reduction by Dutasteride of Cancer Events (REDUCE) study.
    Bostwick, D. G.
    Tindall, D. J.
    Pettaway, C. A.
    Tammela, T. L.
    Teloken, C.
    Wilson, T. H.
    Castro, R. S.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [23] Dutasteride Improves Outcomes of Benign Prostatic Hyperplasia When Evaluated for Prostate Cancer Risk Reduction: Secondary Analysis of the REduction by Dutasteride of Prostate Cancer Events (REDUCE) Trial EDITORIAL COMMENT
    Madersbacher, Stephan
    [J]. UROLOGY, 2011, 78 (03) : 646 - 647
  • [24] Metabolic syndrome-like components and prostate cancer risk: results from the Reduction by Dutasteride of Prostate Cancer Events (REDUCE) study
    Sourbeer, Katharine N.
    Howard, Lauren E.
    Andriole, Gerald L.
    Moreira, Daniel M.
    Castro-Santamaria, Ramiro
    Freedland, Stephen J.
    Vidal, Adriana C.
    [J]. BJU INTERNATIONAL, 2015, 115 (05) : 736 - 743
  • [25] LOGISTIC REGRESSION MODELING OF FACTORS AFFECTING RATES OF HIGH GRADE PROSTATE CANCER IN THE REDUCTION BY DUTASTERIDE OF PROSTATE CANCER EVENTS (REDUCE) STUDY
    Andriole, Gerald L.
    Tindall, Donald J.
    Tamella, Tuevo L. J.
    Somerville, Matthew C.
    Rittmaster, Roger S.
    [J]. JOURNAL OF UROLOGY, 2011, 185 (04): : E518 - E519
  • [26] Worldwide comparison of prostate needle biopsy quality in the reduction by dutasteride of prostate cancer events (REDUCE) study: Improvement with investigator training
    Bostwick, D. G.
    Teloken, C.
    Brawley, O. W.
    Marberger, M.
    Qian, J.
    Drewnowska, K.
    Niyuhire, F.
    Rittmaster, R. R.
    Fowler, I. L.
    Somerville, M. C.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [27] BENEFITS AND HARMS OF DUTASTERIDE FOR PROSTATE CANCER IN THE RE-BIOPSY POPULATION FOR YEARS 1-2: A RE-ANALYSIS OF REDUCTION BY DUTASTERIDE OF PROSTATE CANCER EVENTS (REDUCE) TRIAL
    Mir, Maria Carmen
    Li, Jianbo
    Kattan, Michael
    Jones, J. S.
    Stephenson, Andrew
    [J]. JOURNAL OF UROLOGY, 2014, 191 (04): : E817 - E817
  • [28] DOES INSULIN RESISTANCE CREATE A BIGGER PROSTATE? RESULTS FROM THE REDUCTION BY DUTASTERIDE OF PROSTATE CANCER EVENTS (REDUCE) TRIAL
    Daniels, James P.
    Mirocha, James
    Zheng, Renning
    Moreira, Daniel M.
    Freedland, Stephen J.
    [J]. JOURNAL OF UROLOGY, 2024, 211 (05): : E78 - E78
  • [29] Statin use and longitudinal changes in prostate volume; results from the REduction by DUtasteride of prostate Cancer Events (REDUCE) trial
    Allott, Emma H.
    Csizmadi, Ilona
    Howard, Lauren E.
    Muller, Roberto L.
    Moreira, Daniel M.
    Andriole, Gerald L.
    Roehrborn, Claus G.
    Freedland, Stephen J.
    [J]. BJU INTERNATIONAL, 2020, 125 (02) : 226 - 233
  • [30] Re: Dutasteride Improves Outcomes of Benign Prostatic Hyperplasia When Evaluated for Prostate Cancer Risk Reduction: Secondary Analysis of the Reduction by Dutasteride of Prostate Cancer Events Trial
    Oelke, Matthias
    [J]. EUROPEAN UROLOGY, 2012, 61 (03) : 624 - 625
12345